framycetin has been researched along with Cholangitis in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (28.57) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Cheng, NS; Hu, HJ; Li, FY; Ma, WJ; Shi, YJ; Wang, JK; Wu, ZR; Yang, Q | 1 |
| Bu, LN; Chang, MH; Chen, AC; Chen, HL; Hsu, HY; Lai, MW; Lee, IH; Lien, TH; Ni, YH; Shih, HH; Wu, JF | 1 |
| Fabris, L; Fiorotto, R; Hoque, R; Scirpo, R; Spirli, C; Strazzabosco, M; Trauner, M | 1 |
| Bu, LN; Chang, CJ; Chang, MH; Chen, HL; Hsu, HY; Hsu, WM; Lai, HS; Ni, YH | 1 |
| DeFelice, AR; Mones, RL; Preud'Homme, D | 1 |
| Arr, M; Biró, L; Iván, E; Perényi, T | 2 |
4 trial(s) available for framycetin and Cholangitis
| Article | Year |
|---|---|
Use of Lactobacillus casei rhamnosus to Prevent Cholangitis in Biliary Atresia After Kasai Operation.
Topics: Anti-Bacterial Agents; Biliary Atresia; Body Weight; Cholangitis; Disease-Free Survival; Escherichia coli; Feces; Female; Humans; Infant; Infant, Newborn; Lacticaseibacillus casei; Lacticaseibacillus rhamnosus; Lactobacillus; Male; Neomycin; Pilot Projects; Portoenterostomy, Hepatic; Probiotics; Recurrence | 2015 |
Prophylactic oral antibiotics in prevention of recurrent cholangitis after the Kasai portoenterostomy.
Topics: Antibiotic Prophylaxis; Biliary Atresia; Child, Preschool; Cholangitis; Drug Therapy, Combination; Female; Humans; Infant; Infant, Newborn; Life Tables; Male; Neomycin; Portoenterostomy, Hepatic; Postoperative Complications; Prospective Studies; Recurrence; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination | 2003 |
[Pharmacokinetics and clinical therapy with carbenicillin].
Topics: Ampicillin; Bacillus; Chloramphenicol; Cholangitis; Cholecystitis; Clinical Trials as Topic; Escherichia coli; Humans; Kidney; Neomycin; Penicillins; Polymyxins; Proteus; Pyelonephritis; Streptomycin | 1970 |
[Pharmacokinetics and pharmacokinetic studies with carbenicillin].
Topics: Ampicillin; Chloramphenicol; Cholangitis; Cholecystitis; Clinical Trials as Topic; Escherichia coli; Humans; Kidney; Neomycin; Penicillins; Polymyxins; Proteus; Pyelonephritis; Streptomycin | 1970 |
3 other study(ies) available for framycetin and Cholangitis
| Article | Year |
|---|---|
Biliary antibiotics irrigation for E. coli-induced chronic proliferative cholangitis and hepatolithiasis: A pathophysiological study in rabbits.
Topics: Animals; Anti-Bacterial Agents; Bacitracin; Chlorhexidine; Cholangitis; Chronic Disease; Collagen Type I; Cytokines; Drug Combinations; Escherichia coli; Escherichia coli Infections; Lipopolysaccharides; Lithiasis; Liver Diseases; Metronidazole; Neomycin; Nitrofurazone; Ofloxacin; Polymyxin B; Povidone-Iodine; Rabbits; Therapeutic Irrigation; Vascular Endothelial Growth Factor A | 2020 |
Loss of CFTR affects biliary epithelium innate immunity and causes TLR4-NF-κB-mediated inflammatory response in mice.
Topics: Animals; Anti-Bacterial Agents; Bile Ducts; Cholagogues and Choleretics; Cholangitis; Colitis; Cytokines; Dextran Sulfate; Disease Models, Animal; Epithelial Cells; HEK293 Cells; Humans; Immunity, Innate; Inflammation Mediators; Keratin-19; Leukocyte Common Antigens; Lipopolysaccharides; Mice; Mice, Inbred C57BL; Mice, Inbred CFTR; Mice, Knockout; Neomycin; NF-kappa B; Phosphorylation; Polymyxin B; src-Family Kinases; Time Factors; Toll-Like Receptor 4; Transfection; Ursodeoxycholic Acid | 2011 |
Use of neomycin as the prophylaxis against recurrent cholangitis after Kasai portoenterostomy.
Topics: Administration, Oral; Biliary Atresia; Cholangitis; Female; Humans; Infant, Newborn; Neomycin; Portoenterostomy, Hepatic; Postoperative Complications; Prognosis; Recurrence; Time Factors | 1994 |